The combination of BET and PARP inhibitors is synergistic in models of cholangio
- This topic has 0 replies, 1 voice, and was last updated 4 years, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/31605774
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.